Skip to main content
. 2019 May 5;9(5):e028466. doi: 10.1136/bmjopen-2018-028466

Figure 1.

Figure 1

Diagram showing patient selection and allocation to MTX-exposed and non-MTX-exposed groups. CRF, case report form; csDMARDs, conventional synthetic disease-modifying antirheumatic drugs; ILD, interstitial lung disease; MTX, methotrexate.